A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
2022-06-27
عنوان الدراسة
A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
داعم الدراسة
Modus Therapeutics AB
دواء الدراسة
Sevuparin
رقم بروتوكول الدراسة
TVOC01
حالة الدراسة
Ongoing
موقع الدراسة
KKUH
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。